DE60329614D1 - POLYMERIC COMPOSITION AND PHARMACEUTICAL FORMS CONTAINING THEREOF - Google Patents

POLYMERIC COMPOSITION AND PHARMACEUTICAL FORMS CONTAINING THEREOF

Info

Publication number: DE60329614D1
Authority: DE; Germany
Prior art keywords: polymeric composition; pharmaceutical forms; forms containing; pharmaceutical; polymeric
Prior art date: 2002-09-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60329614T

Other languages

German (de)

Inventor

Jen-Chi Chen

Frank J Bunick

Harry S Sowden

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kenvue Brands LLC

Original Assignee

McNeil PPC Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-28

Filing date

2003-03-21

Publication date

2009-11-19

2002-09-28 Priority claimed from PCT/US2002/031062 external-priority patent/WO2003026626A2/en

2003-03-21 Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc

2003-03-21 Priority claimed from PCT/US2003/008960 external-priority patent/WO2004028514A1/en

2009-11-19 Application granted granted Critical

2009-11-19 Publication of DE60329614D1 publication Critical patent/DE60329614D1/en

2023-03-22 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

DE60329614T 2002-09-28 2003-03-21 POLYMERIC COMPOSITION AND PHARMACEUTICAL FORMS CONTAINING THEREOF Expired - Lifetime DE60329614D1 (en)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
PCT/US2002/031062 WO2003026626A2 (en)	2001-09-28	2002-09-28	Modified release dosage forms
PCT/US2002/031024 WO2003026625A1 (en)	2001-09-28	2002-09-28	Modified release dosage forms
PCT/US2002/031129 WO2003026630A1 (en)	2001-09-28	2002-09-28	Dosage forms having an inner core and outer shell with different shapes
PCT/US2002/031163 WO2003026627A1 (en)	2001-09-28	2002-09-28	Composite dosage forms
PCT/US2002/031117 WO2003026629A2 (en)	2001-09-28	2002-09-28	Modified release dosage forms
PCT/US2003/008960 WO2004028514A1 (en)	2002-09-28	2003-03-21	Polymer composition and dosage forms comprising the same

Publications (1)

Publication Number	Publication Date
DE60329614D1 true DE60329614D1 (en)	2009-11-19

Family

ID=34271652

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE60329614T Expired - Lifetime DE60329614D1 (en)	2002-09-28	2003-03-21	POLYMERIC COMPOSITION AND PHARMACEUTICAL FORMS CONTAINING THEREOF
DE60335270T Expired - Lifetime DE60335270D1 (en)	2002-09-28	2003-03-21	PHARMACEUTICAL FORMS FOR DELAYED RELEASE WITH TWO NUCLEARS AND ONE OPENING

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE60335270T Expired - Lifetime DE60335270D1 (en)	2002-09-28	2003-03-21	PHARMACEUTICAL FORMS FOR DELAYED RELEASE WITH TWO NUCLEARS AND ONE OPENING

Country Status (8)

Country	Link
JP (3)	JP2006517182A (en)
CN (3)	CN1700907A (en)
AT (1)	ATE444739T1 (en)
AU (4)	AU2003220466A1 (en)
BR (5)	BR0314787A (en)
CA (3)	CA2500311A1 (en)
DE (2)	DE60329614D1 (en)
MX (1)	MXPA05003283A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2470463C (en)	2004-06-09	2012-09-18	Lornamead Brands, Inc.	Tooth whitening products and methods of making the same
SA07280459B1 (en) *	2006-08-25	2011-07-20	بيورديو فارما إل. بي.	Tamper Resistant Oral Pharmaceutical Dosage Forms Comprising an Opioid Analgesic
WO2009153635A1 (en) *	2008-06-19	2009-12-23	University Of Witwatersrand, Johannesburg	A chronotherapeutic pharmaceutical dosage form
US20130011449A1 (en) *	2010-03-23	2013-01-10	Shiori Tomioka	Solid preparation
WO2013009701A2 (en) *	2011-07-08	2013-01-17	The University Of North Carolina At Chapel Hill	Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
HK1203162A1 (en) *	2012-02-07	2015-10-23	麦克内尔-Ppc股份有限公司	Rapidly disintegrating coated tablets
WO2013183497A1 (en) *	2012-06-05	2013-12-12	武田薬品工業株式会社	Dry-coated tablet
AU2015317469B2 (en) *	2014-09-19	2018-03-15	The Procter & Gamble Company	Pulsed release phenylephrine dosage forms
KR102810926B1 (en)	2017-12-20	2025-05-22	퍼듀 퍼머 엘피	Abuse-deterrent morphine sulfate formulation
MX2020006886A (en) *	2017-12-29	2020-11-11	Laxxon Medical Ag	Drug delivery system.
US12409163B2 (en)	2021-07-30	2025-09-09	Evecxia Therapeutics, Inc.	Method of enhancing 5-hydroxytryptophan (5-HTP) exposure
MX2024001390A (en) *	2021-07-30	2024-05-17	Evecxia Therapeutics Inc	5-hydroxytryptophan gastroretentive dosage forms.
CN115295864B (en) *	2021-11-09	2023-08-11	深圳市德方创域新能源科技有限公司	Positive electrode lithium supplementing additive and preparation method and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0662824A1 (en) *	1992-09-30	1995-07-19	Pfizer Inc.	Article containing a core and a coating having a non constant thickness
GB9402203D0 (en) *	1994-02-04	1994-03-30	Smithkline Beecham Plc	Pharmaceutical formulation
DE4431653C2 (en) *	1994-09-06	2000-01-20	Lohmann Therapie Syst Lts	Coated tablet for the controlled release of active substances, a process for their preparation and their use
IT1282576B1 (en) *	1996-02-06	1998-03-31	Jagotec Ag	PHARMACEUTICAL TABLET SUITABLE TO GIVE THE ACTIVE SUBSTANCE IN SUBSEQUENT AND PREDETERMINABLE TIMES
US6602521B1 (en) *	1998-09-29	2003-08-05	Impax Pharmaceuticals, Inc.	Multiplex drug delivery system suitable for oral administration
EP1275373A4 (en) *	2000-04-17	2007-04-04	Astellas Pharma Inc	Drug delivery system for avoiding pharmacokinetic interaction between drugs and method thereof
PT1368006E (en) *	2001-02-13	2006-08-31	Astrazeneca Ab	NEW MODIFIED LIBERTACAO FORMULA

2003
- 2003-03-21 CA CA002500311A patent/CA2500311A1/en not_active Abandoned
- 2003-03-21 CA CA002500312A patent/CA2500312A1/en not_active Abandoned
- 2003-03-21 DE DE60329614T patent/DE60329614D1/en not_active Expired - Lifetime
- 2003-03-21 CA CA2500313A patent/CA2500313C/en not_active Expired - Fee Related
- 2003-03-21 BR BR0314787-8A patent/BR0314787A/en not_active IP Right Cessation
- 2003-03-21 JP JP2004539769A patent/JP2006517182A/en active Pending
- 2003-03-21 AU AU2003220466A patent/AU2003220466A1/en not_active Abandoned
- 2003-03-21 AU AU2003218359A patent/AU2003218359A1/en not_active Abandoned
- 2003-03-21 CN CN03825324.0A patent/CN1700907A/en active Pending
- 2003-03-21 JP JP2004539770A patent/JP2006517183A/en active Pending
- 2003-03-21 CN CN03825331.3A patent/CN1700908A/en active Pending
- 2003-03-21 AT AT03714356T patent/ATE444739T1/en not_active IP Right Cessation
- 2003-03-21 BR BR0314777-0A patent/BR0314777A/en not_active Application Discontinuation
- 2003-03-21 BR BR0314804-1A patent/BR0314804A/en not_active Application Discontinuation
- 2003-03-21 AU AU2003225944A patent/AU2003225944A1/en not_active Abandoned
- 2003-03-21 JP JP2004539767A patent/JP2006517514A/en active Pending
- 2003-03-21 CN CN03823065.8A patent/CN1684671A/en active Pending
- 2003-03-21 AU AU2003220472A patent/AU2003220472A1/en not_active Abandoned
- 2003-03-21 MX MXPA05003283A patent/MXPA05003283A/en unknown
- 2003-03-21 DE DE60335270T patent/DE60335270D1/en not_active Expired - Lifetime
- 2003-03-21 BR BR0314781-9A patent/BR0314781A/en not_active Application Discontinuation
- 2003-03-21 BR BR0314547-6A patent/BR0314547A/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2003218359A1 (en)	2004-04-19
CA2500312A1 (en)	2004-04-08
MXPA05003283A (en)	2005-11-23
CA2500313C (en)	2011-06-07
CN1700907A (en)	2005-11-23
BR0314547A (en)	2005-08-09
BR0314787A (en)	2005-07-26
JP2006517183A (en)	2006-07-20
AU2003225944A1 (en)	2004-04-19
JP2006517182A (en)	2006-07-20
CA2500311A1 (en)	2004-04-08
JP2006517514A (en)	2006-07-27
AU2003220466A1 (en)	2004-04-19
BR0314781A (en)	2005-07-26
DE60335270D1 (en)	2011-01-20
ATE444739T1 (en)	2009-10-15
BR0314777A (en)	2005-07-26
CN1700908A (en)	2005-11-23
AU2003220472A1 (en)	2004-04-19
CN1684671A (en)	2005-10-19
BR0314804A (en)	2005-08-02
CA2500313A1 (en)	2004-04-08

Publication	Publication Date	Title
FI20011478L (en)	2003-01-06	Pharmaceutical composition
ATE401800T1 (en)	2008-08-15	HIGHLY INTENSIVE SWEETENER COMPOSITION AND DELIVERY THEREOF
DE60335282D1 (en)	2011-01-20	POLYCARBONATE RESIN COMPOSITION AND FORM BODY THEREOF
DE60331324D1 (en)	2010-04-01	Polycarbonate composition and moldings
EP1298180A4 (en)	2005-03-09	HYDROFUGE AND OLEOFUE COMPOSITION
PT1501534E (en)	2006-09-29	PHARMACEUTICAL FORMULATIONS
EP1513825A4 (en)	2011-01-05	ANTI-TUBERCULOUS DRUG: COMPOSITIONS AND METHODS
IL170758A0 (en)	2011-08-01	7-amino-isoindolyl compounds and their pharmaceutical uses
DE60209252D1 (en)	2006-04-20	Stabilized Polymer Composition
EP1425019A4 (en)	2004-11-17	PHARMACEUTICAL COMPOSITION
PT1467724E (en)	2006-08-31	AGOMELATIN ORODISPERSAVEL PHARMACEUTICAL COMPOSITION
EP1512408A4 (en)	2008-01-23	ANTIBACTERIAL AGENT AND ANTIBACTERIAL COMPOSITION
DE60334379D1 (en)	2010-11-11	COPOLYMER COMPOUND, POLYMER COMPOSITION THEREIN, PICTURE PRODUCTION METHOD AND THE PICTURE GENERATING USE THEREOF
DE60312049D1 (en)	2007-04-05	STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING AN AMORPHANT AGENT
DK1587478T3 (en)	2013-10-21	PHARMACEUTICAL COMPOSITION
DE60329614D1 (en)	2009-11-19	POLYMERIC COMPOSITION AND PHARMACEUTICAL FORMS CONTAINING THEREOF
FI20022128A0 (en)	2002-12-03	Pharmaceutical composition
PL361518A1 (en)	2004-02-09	Application of the substance and pharmaceutical composition
PT1558263E (en)	2006-10-31	PROLONGED LIBERATION PHARMACEUTICAL COMPOSITION
DE60217390D1 (en)	2007-02-15	BICALUTAMIDE-CONTAINING PHARMACEUTICAL COMPOSITION
DE60322926D1 (en)	2008-09-25	PHOTOPOLYMERIZABLE COMPOSITION AND USE THEREOF
DK1474152T3 (en)	2007-04-10	Orodispersible pharmaceutical composition comprising ivabradine
DK1467750T3 (en)	2006-11-13	Orodispersible pharmaceutical composition comprising perindopril
DE60321641D1 (en)	2008-07-31	Photopolymerizable initiator combination and photopolymerizable composition
DE60334283D1 (en)	2010-11-04	INK COMPOSITION AND INK IRRIGATION METHOD

Legal Events

Date	Code	Title	Description
2010-10-28	8364	No opposition during term of opposition